or Try an Advanced Search...

    Tyrosine Kinase Stocks List

    Symbol Grade Name % Change
    RIGL B Rigel Pharmaceuticals, Inc. 3.00
    BPMC B Blueprint Medicines Corporation 1.91
    EXEL B Exelixis, Inc. 0.52
    NRIX C Nurix Therapeutics, Inc. -1.19
    AVBP C ArriVent BioPharma, Inc. -2.99
    PBYI C Puma Biotechnology Inc 2.11
    KALA C Kala Pharmaceuticals, Inc. 1.87
    COGT D Cogent Biosciences, Inc. -1.10
    EYPT D EyePoint Pharmaceuticals, Inc. -6.76
    KRON D Kronos Bio, Inc. 1.66
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Protein Kinase Inhibitor Biopharmaceutical Enzymes Solid Tumors Tyrosine Kinase Receptors Biology Biotechnology Eye Fibroblast Growth Factor Receptor Glucocorticoids Inflammation Macular Degeneration Medicine Non Small Cell Lung Cancer Ophthalmic Organ Systems Organic Compounds Proto Oncogene Tyrosine Protein Kinase Src Treatment Of Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase stocks.

    Symbol Grade Name Weight
    HRTS F Tema Cardiovascular and Metabolic ETF 3.69
    CANC D Tema Oncology ETF 1.64
    WDNA D WisdomTree BioRevolution Fund 1.59
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 1.43
    BBP C BioShares Biotechnology Products Fund 1.19
    View all Tyrosine Kinase ETFs...
    Compare ETFs
    Compare CANC to BBP Compare HRTS to WDNA Compare WDNA to BBC

        Tyrosine Kinase Stocks Recent News

        Date Stock Title
        Nov 21 EXEL 3 Reasons Growth Investors Will Love Exelixis (EXEL)
        Nov 21 PBYI PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer
        Nov 21 PBYI Puma commences Phase II trial of alisertib for breast cancer treatment
        Nov 20 NRIX Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
        Nov 20 PBYI Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
        Nov 20 EXEL Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity
        Nov 19 RIGL How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%
        Nov 19 RIGL Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive
        Nov 18 RIGL 5 Relative Price Strength Options Available for Investors
        Nov 17 NRIX Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
        Nov 17 KRON Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
        Nov 16 KRON Kronos Bio Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 BPMC Blueprint Medicines' Growth With AYVAKIT And Next-Gen Oncology Drugs
        Nov 15 RIGL Exploring Three High Growth Tech Stocks in the United States
        Nov 15 AVBP ArriVent BioPharma GAAP EPS of -$0.61 beats by $0.11
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Protein Kinase Inhibitor Biopharmaceutical Enzymes Solid Tumors Tyrosine Kinase Receptors Biology Biotechnology Eye Fibroblast Growth Factor Receptor Glucocorticoids Inflammation Macular Degeneration Medicine Non Small Cell Lung Cancer Ophthalmic Organ Systems Organic Compounds Proto Oncogene Tyrosine Protein Kinase Src Treatment Of Cancer
        Tyrosine Kinase

        Tyrosine kinase is an enzyme that catalyzes the transfer of phosphate groups from ATP to tyrosine residues on proteins. It is involved in many cellular processes, including cell growth, differentiation, and migration. Tyrosine kinases are also involved in signal transduction pathways, which are important for cell communication and regulation. Mutations in tyrosine kinases can lead to cancer and other diseases.

        Browse All Tags